Category Archives: GlaxoSmithKline (Pakistan) Limited (GLAXO)

GlaxoSmithKline (Pakistan) Limited (GLAXO)

Company Date Announcements GlaxoSmithKline (Pakistan) Limited (GLAXO) April 24th, 2019 02:43:25 PM FINANCIAL RESULT FOR THE FIRST QUARTER ENDED 31/03/2019 PROFIT/LOSS BEFORE TAXATION RS. IN MILLION 817.623 PROFIT/LOSS AFTER TAXATION RS. IN MILLION 532.910 EPS = 1.67

Posted in GlaxoSmithKline (Pakistan) Limited (GLAXO) | Leave a comment

GlaxoSmithKline (Pakistan) Limited (GLAXO)

Company Date Announcements GlaxoSmithKline (Pakistan) Limited (GLAXO) March 4th, 2019 04:53:04 PM FINANCIAL RESULT FOR THE YEAR ENDED 31/12/2018 PROFIT/LOSS BEFORE TAXATION RS. IN MILLION 4,692.117 PROFIT/LOSS AFTER TAXATION RS. IN MILLION 3,257.951 EPS = 10.23 DIVIDEND = 70%(F) ANNUAL … Continue reading

Posted in GlaxoSmithKline (Pakistan) Limited (GLAXO) | Leave a comment

GlaxoSmithKline (Pakistan) Limited (GLAXO)

Company Date Announcements GlaxoSmithKline (Pakistan) Limited (GLAXO) August 13th, 2018 03:10:01 PM FINANCIAL RESULT FOR THE HALF YEAR ENDED 30/06/2018 PROFIT/LOSS BEFORE TAXATION RS. IN MILLION 2,222.945 PROFIT/LOSS AFTER TAXATION RS. IN MILLION 1,330.314 EPS = 4.18

Posted in GlaxoSmithKline (Pakistan) Limited (GLAXO) | Leave a comment

GlaxoSmithKline (Pakistan) Limited (GLAXO)

Company Date Announcements GlaxoSmithKline (Pakistan) Limited (GLAXO) April 24th, 2018 04:07:23 PM FINANCIAL RESULT FOR THE FIRST QUARTER ENDED 31/03/2018 PROFIT/LOSS BEFORE TAXATION RS. IN MILLION 1,402.847 PROFIT/LOSS AFTER TAXATION RS. IN MILLION 914.740 EPS = 2.87

Posted in GlaxoSmithKline (Pakistan) Limited (GLAXO) | Leave a comment

GlaxoSmithKline (Pakistan) Limited (GLAXO)

Company Date Announcements GlaxoSmithKline (Pakistan) Limited (GLAXO) February 27th, 2018 03:59:12 PM FINANCIAL RESULT FOR THE YEAR ENDED 31/12/2017 PROFIT/LOSS BEFORE TAXATION RS. IN MILLION 4,925.414 PROFIT/LOSS AFTER TAXATION RS. IN MILLION 2,981.023 EPS = 9.36 DIVIDEND = 40% ANNUAL … Continue reading

Posted in GlaxoSmithKline (Pakistan) Limited (GLAXO) | Leave a comment